Total Funding
56
Total FundingSeries B raised
Growth Score in past quarter
pts
Heat Score 56 in past quarter
17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Semafore Pharmaceuticals discovers and develops clinical-stage drugs.
About the Company
Semafore Pharmaceuticals is a development-stage drug discovery company that targets the PI3K cell signaling pathways to create anti-cancer drugs. Their PI3K inhibitors are used to treat tumors and have the potential to treat cancers of the brain, lungs, and hemological systems.
